Cooperative Agreement U58DP003832

Federal Grant Award Summary The Epilepsy Foundation of America received a $248,832 Project Grant from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, awarded September 15, 2025, with completion targeted for June 30, 2027. This planning grant supports the development of methods and infrastructure to conduct rigorous health disparities research within the Epilepsy...

This is a Cooperative Agreement awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program. The $3,940,692.87 award, effective May 1, 2025 through April 30, 2029, will support a multi-site Phase 3 randomized controlled clinical trial to examine the efficacy of an e-health behavioral intervention to improve executive functioning in adolescents with...

The U.S. Defense Health Agency awarded a $224,541 Project Grant to the VA Connecticut Research & Education Foundation, Inc. to increase epilepsy self-management access for veterans through a partnered hub and spoke model. This grant is funded under the Military Medical Research and Development program (CFDA 12.420), which supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The grant project aims to develop and...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $426,250 Project Grant under CFDA 93.853, Extramural Research Programs in the Neurosciences and Neurological Disorders, to the Regents of the University of Minnesota, Office of Sponsored Projects Administration. This 2-year grant will fund research using cutting-edge voltage imaging to examine how interactions between specific neuronal circuit elements in the hippocampus relate to the development of temporal lobe...

Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded Cleveland Clinic Lerner College of Medicine of Case Western Reserve University a Project Grant of $207,002 under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, effective August 1, 2025, through July 31, 2030. The award supports Dr. Anny Reyes, Ph.D., in developing the Healthy Aging in People with Epilepsy Program (HAP-E), a...

This $199,005 National Science Foundation project grant funds research at the University of North Florida to develop machine learning algorithms using noninvasive wearable sensors to forecast seizures and optimize antiseizure medication dosing for women with epilepsy. Funded under the NSF's Engineering program (CFDA 47.041), which supports innovation and excellence in engineering research and education, the two-year award will investigate hormonal changes associated with the menstrual cycle...

This federal Project Grant award of $225,599, awarded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, will support research on the contributions of sex chromosomes versus gonadal hormones in shaping sex differences in epilepsy. The University of Illinois, the awardee, will utilize in vivo video-electroencephalography, RNA sequencing, and immunostaining to determine...

Federal Grant Award Summary Vanderbilt University Medical Center received a $512,438 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective September 16, 2025, through August 31, 2030. The SHIFT (Scaling Up Task-Shifted Epilepsy Care) project addresses the global treatment gap for people with epilepsy (PWE), particularly in low- and...

This $427,625 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to evaluate the use of hyperpolarized 13C magnetic resonance imaging (HPMRI) as a novel diagnostic tool for identifying epileptic tissue. The research aims to: 1) Use a rat model of temporal lobe epilepsy to explore the ability of [1-13C]pyruvate HPMRI to...

Federal Grant Award Summary The National Institute of Neurological Disorders and Stroke (NINDS) awarded $234,630 to Massachusetts General Hospital (MGH) on August 1, 2025, under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. This K23 mentored patient-oriented research project, extending through July 31, 2030, investigates the neurophysiological basis of cognitive impairment in epilepsy patients over multi-day timescales. The research...